ACXP Acurx Pharmaceuticals Inc. Quick Ratio

ACXP (Acurx Pharmaceuticals, Inc.) - company brandmark

Acurx Pharmaceuticals (ACXP) is developing innovative antibiotics to combat resistant superbugs, leveraging support from the CDC and the success of irezamicin. This price chart with the 4.00 indicator illustrates the price action of an asset whose potential depends on future drug supplies to the hospital sector. The company is currently in a pre-commercial phase, utilizing its existing capital to complete the necessary research.

ACXP: Acurx Pharmaceuticals, Inc. Intermediate Coverage Ratio 07/04/2022 - 10/29/2026

Summary analytical data breakdowns for Acurx Pharmaceuticals (ACXP)

- market value and analyst target forecast:
Price Chart acurxpharma.com|ACXP - Consensus Target
- market capitalization data:
Market Capitalization Acurx|ACXP - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value per Share Acurx Pharmaceuticals|ACXP - Accounting Value of Company|Market Value to Book Value Ratio acurxpharma.com|ACXP - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Acurx Pharmaceuticals|ACXP - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital acurxpharma.com|ACXP - Company Total Debt|Debt to Book Capitalization Ratio Acurx|ACXP - Company Long-Term Loans and Borrowings|Company Short-Term Debt Acurx Pharmaceuticals|Quick Ratio acurxpharma.com
- earnings and valuation multiples information:
ACXP - Company Net Income
Basic company analysis:Acurx Pharmaceuticals
Flagship merchandise of Acurx Pharmaceuticals

Acurx Pharmaceuticals (ACXP) attracts top microbiology specialists through an RSU system and an academic culture. Analyzing the recorded quick liquidity ratio on GURU.Markets, an investor can see the company's ability to meet its obligations using cash and accounts receivable. This indicator excludes illiquid inventories, revealing real financial stability without accounting for goods. High values confirm reliability but may indicate inefficient capital allocation.

Who Acurx Pharmaceuticals competes with

Armata Pharma (ARMP) - Quick Liquidity